Free Trial

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Invests $244,000 in Grail, Inc. (NASDAQ:GRAL)

Grail logo with Medical background

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 14,939 shares of the company's stock, valued at approximately $244,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Van ECK Associates Corp acquired a new position in Grail in the fourth quarter valued at about $475,000. Gladstone Institutional Advisory LLC bought a new stake in shares of Grail during the fourth quarter worth about $259,000. Moloney Securities Asset Management LLC bought a new stake in shares of Grail during the fourth quarter worth about $559,000. Wilmington Savings Fund Society FSB bought a new stake in Grail in the fourth quarter valued at approximately $64,000. Finally, abrdn plc bought a new stake in Grail in the fourth quarter valued at approximately $3,768,000.

Analyst Ratings Changes

Several brokerages recently commented on GRAL. Wolfe Research initiated coverage on Grail in a report on Friday, November 15th. They issued a "peer perform" rating on the stock. Morgan Stanley began coverage on Grail in a research report on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 target price on the stock.

View Our Latest Stock Report on Grail

Grail Trading Up 4.6 %

Grail stock traded up $2.44 during trading on Monday, hitting $55.02. 3,152,661 shares of the company were exchanged, compared to its average volume of 1,200,835. The business's 50 day moving average is $23.94 and its 200 day moving average is $18.13. Grail, Inc. has a 52 week low of $12.33 and a 52 week high of $55.32.

Grail Company Profile

(Free Report)

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

Further Reading

Institutional Ownership by Quarter for Grail (NASDAQ:GRAL)

Should You Invest $1,000 in Grail Right Now?

Before you consider Grail, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.

While Grail currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The EXACT Date of Next Stock Market Crash
HIMS Stock Up 120%! More Growth Ahead?
How to Find the BEST Penny Stocks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines